Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
55.96
+2.98 (5.62%)
Jul 30, 2026, 4:00 PM EDT - Market closed
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $8.08 billion as of July 30, 2026. Its market cap has increased by 80.62% in one year.
Market Cap
8.08B
Enterprise Value
6.46B
1-Year Change
80.62%
Ranking
Category
Stock Price
$55.96
ChartMarket Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $8.08B, an increase of 485.56%. That is a compound annual growth rate of 33.44%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 8.08B | 33.78% |
| Dec 31, 2025 | 6.04B | -40.80% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Crinetics Pharmaceuticals | 8.84B |
| Protagonist Therapeutics | 8.80B |
| Spyre Therapeutics | 8.79B |
| Kymera Therapeutics | 8.73B |
| Praxis Precision Medicines | 8.25B |
| Immunovant | 8.03B |
| TG Therapeutics | 7.78B |
| Rhythm Pharmaceuticals | 7.40B |